1. Home
  2. ONCY vs BGSF Comparison

ONCY vs BGSF Comparison

Compare ONCY & BGSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
  • BGSF
  • Stock Information
  • Founded
  • ONCY 1998
  • BGSF 2007
  • Country
  • ONCY Canada
  • BGSF United States
  • Employees
  • ONCY N/A
  • BGSF N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • BGSF Professional Services
  • Sector
  • ONCY Health Care
  • BGSF Consumer Discretionary
  • Exchange
  • ONCY Nasdaq
  • BGSF Nasdaq
  • Market Cap
  • ONCY 49.1M
  • BGSF 54.8M
  • IPO Year
  • ONCY 1999
  • BGSF N/A
  • Fundamental
  • Price
  • ONCY $0.52
  • BGSF $3.41
  • Analyst Decision
  • ONCY Strong Buy
  • BGSF Strong Buy
  • Analyst Count
  • ONCY 3
  • BGSF 1
  • Target Price
  • ONCY $4.33
  • BGSF $9.00
  • AVG Volume (30 Days)
  • ONCY 333.0K
  • BGSF 17.1K
  • Earning Date
  • ONCY 05-14-2025
  • BGSF 05-07-2025
  • Dividend Yield
  • ONCY N/A
  • BGSF N/A
  • EPS Growth
  • ONCY N/A
  • BGSF N/A
  • EPS
  • ONCY N/A
  • BGSF N/A
  • Revenue
  • ONCY N/A
  • BGSF $266,968,000.00
  • Revenue This Year
  • ONCY N/A
  • BGSF $4.90
  • Revenue Next Year
  • ONCY N/A
  • BGSF N/A
  • P/E Ratio
  • ONCY N/A
  • BGSF N/A
  • Revenue Growth
  • ONCY N/A
  • BGSF N/A
  • 52 Week Low
  • ONCY $0.47
  • BGSF $2.91
  • 52 Week High
  • ONCY $1.53
  • BGSF $9.26
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 41.53
  • BGSF 50.65
  • Support Level
  • ONCY $0.54
  • BGSF $3.20
  • Resistance Level
  • ONCY $0.65
  • BGSF $3.59
  • Average True Range (ATR)
  • ONCY 0.04
  • BGSF 0.24
  • MACD
  • ONCY -0.00
  • BGSF 0.05
  • Stochastic Oscillator
  • ONCY 13.36
  • BGSF 62.24

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About BGSF BGSF Inc.

BGSF Inc is a provider of workforce solutions operating primarily in the U.S. across two segments: Property Management and Professional. In the Property Management segment, BGSF offers office and maintenance talent to clients, facilitating their staffing needs with short-term and consulting solutions. The Professional segment specializes in IT, offering skilled professionals in SAP, Workday, and other areas to Fortune 500 companies and consulting firms nationwide. BGSF's workforce services include on-demand assignments, consulting, and managed solutions, allowing clients to flexibly manage their workforce needs. With a focus on converting fixed personnel costs to variable expenses, BGSF enables companies to effectively address fluctuations in demand while optimizing costs.

Share on Social Networks: